These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30354550)

  • 1. Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
    Khan MS; Usman MS; Siddiqi TJ; Khan SU; Murad MH; Mookadam F; Figueredo VM; Krasuski RA; Benza RL; Rich JD
    Circ Cardiovasc Qual Outcomes; 2018 Sep; 11(9):e004757. PubMed ID: 30354550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.
    Caldeira D; Loureiro MJ; Costa J; Pinto FJ; Ferreira JJ
    Can J Cardiol; 2014 Aug; 30(8):879-87. PubMed ID: 24986048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
    Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
    Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
    BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.
    Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
    Johnson SR; Mehta S; Granton JT
    Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation in Pulmonary Arterial Hypertension.
    Robinson JC; Pugliese SC; Fox DL; Badesch DB
    Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in connective tissue diseases: an update.
    Aithala R; Alex AG; Danda D
    Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the efficacy of combination therapy and monotherapy in connective tissue disease associated pulmonary arterial hypertension: a systematic review and meta-analysis.
    Pan J; Lei L; Zhao C
    Clin Exp Rheumatol; 2018; 36(6):1095-1102. PubMed ID: 29998831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Papanastasiou CA; Jonnalagadda AK; Oikonomou EK; Theochari CA; Palaiodimos L; Karvounis HI; Armstrong EJ; Faillace RT; Giannakoulas G
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):859-867. PubMed ID: 29724516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
    Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M
    Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis.
    Zhang HC; Wang N; Zhang W; Gu ZC; Liu XY
    Medicine (Baltimore); 2018 Sep; 97(36):e12203. PubMed ID: 30200129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
    Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H
    Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension.
    Roldan T; Villamañán E; Rios JJ; Waxman AB
    Thromb Res; 2017 Dec; 160():83-90. PubMed ID: 29127864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis.
    Wang P; Hu L; Yin Y; Yan D; Zheng H; Zhang J; Li Y
    Thromb Res; 2020 Dec; 196():251-256. PubMed ID: 32920295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of pulmonary arterial hypertension in systemic sclerosis: an update.
    Denton CP; Nihtyanova SI
    Curr Rheumatol Rep; 2007 May; 9(2):158-64. PubMed ID: 17502047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T;
    J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
    Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB
    J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
    J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.